Parkinson and the Males Body Composition

NCT06723210 | Completed

• 1 other identifier: ETICA-ULE-081-2024
• Study Type: observational
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

The main aim of the present study was to ascertain the type of relationship (dependency or independency) among some of the cardinal motor symptoms of the Parkinson´s disease (PD) and the body composition (BC) variables of a group of the male PD´s patients, using the bioelectrical impedance analysis.

Conditions

Neurodegenerative Disease

Keywords

Movement Disorders; Components of the Human Body

Outcome Measures

Primary Outcomes (9)

• The body composition variables or the bioelectrical impedance variables

  weight (kg), fat-free mass in absolute terms (FFMa) (kg), fat-free mass in relative terms (FFMr) (normalized per kg of body mass -kg/kg of body weight-), fat-free mass of the right arm (FFMRA) (kg), fat-free mass of the left arm (FFMLA) (kfg), difference between the FFMRA and the FFMLA (%), fat-free mass of the right leg (FFMRL) (kg), fat-free of the mass left leg (FFMLL) (kg), difference between the FFMRL and the FFMLL (%), body fat mass (BFM) (kg), skeletal muscle mass (SMM) (kg), body mass index (BMI) (kg/m2), percentage body fat (PBF) (%), total body water in absolute terms (TBWa) (L), total body water in relative terms (TBWr) (normalized per kg of body mass -kg/kg of body weight-), total water of the right arm (TWRA) (L), total water of the left arm (TWLA) (L), difference between the TWRA and the TWLA (%), total water of the right leg (TWRL) (L), total water of the left leg (TWLL) (L), difference between the TWRL and the TWLL (%), intracellular water (ICW) (L), extracellular

  From February 2025 to February 2025

• The Movement Disorder Society-Unified Parkinson´s Disease Rating Scale (MDS-UPDRS))

  MDS-UPDRS: Spanish validated version of the MDS-UPDRS. The possible score ranges from 0 to 72 points whereby 0 points represent a healthy status and the more points, the worse health status.

  From February 2025 to February 2025

• The Ten-Meter Walk Test

  The Ten-Meter Walk Test: performance measure used to assess walking speed in meters per second over a short distance (10 meters).

  From February 2025 to February 2025

• Step length

  The step length of the patients will be determined using kinematic gait analysis during the TMWT, utilizing the OptoGait system (Microgait, Optogait, v.1.12.21, Italy). The step length of the patients will be determined in cm. This system consists of transmitter and receiver bars equipped with optical sensors operating at a frequency of 1000 Hz, which will be positioned along the ten-meter walking corridor, from meter two to meter seven.

  From February 2025 to February 2025

• : Spanish validated version of the Disability of the Arm, Shoulder and Hand (DASH)

  DASH: Spanish validated version of the Disability of the Arm, Shoulder and Hand. The possible score ranges from 0 (which means no disability) to 100 (which means most severe disability). Higher scores indicate a greater level of disability and severity, whereas, lower scores indicate a lower level of disability.

  From February 2025 to February 2025

• The Timed up and Go Test (TUG)

  TUG: The TUG measures of functional mobility that was initially developed to identify mobility and balance impairments. Participants takes to rise from a chair, walk three meters, turn around 180 degrees, walk back to the chair, and sit down while turning 180 degrees, as fast as they can (the time of the test is determined in sec).

  From February 2025 to February 2025

• Handgrip Strength of both hands.

  Handgrip Strength of both hands: manual dynamometer measured in kilograms.

  From February 2025 to February 2025

• Static posturography

  Static posturography, assessed by measurement of the center of pressure (CoP). These CoP parameters; Length, in mm, Area in mm2 and Speed, Xspeed and Yspeed in m/s will be combined to report the patient´s static posturography.

  From February 2025 to February 2025

• The nine holes peg test (9-HPT)

  The nine holes peg test (9-HPT) is a brief, standardized, quantitative test of upper extremity function. Both the dominant and non-dominant hands are tested twice. The patient is seated at a table with a small, shallow container holding nine pegs and a wood or plastic block containing nine empty holes. On a start command when a stopwatch is started, the patient picks up the nine pegs one at a time as quickly as possible, puts them in the nine holes, and, once they are in the holes, removes them again as quickly as possible one at a time, replacing them into the shallow container. The total time to complete the task is recorded in minutes. Two consecutive trials with the dominant hand are immediately followed by two consecutive trials with the non-dominant hand. The score for the 9-HPT is an average of the four trials. The two trials for each hand are averaged, converted to the reciprocals of the mean times for each hand and then the two reciprocals are averaged.

  From February 2025 to February 2025

Study Arms (1)

Patients

The patients were assigned to the same group because the study´s design only demands to create one group of patients.

Eligibility Criteria

• Age: 50 Years - 69 Years
• Gender Eligibility Details: The study is focused on the Parkinson´s disease male patients
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

A group of fifteen male patients with idiopathic Parkinson´s disease participated in the project.

You may qualify if:

• (I) Males with diagnosis of idiopathic PD and rated 1-3 on the Hoehn and Yahr Scale.
• (II) No type of dementia as assessed by the mini-mental state examination. (III) Between 50 and 69 years old (a specific range of ages of the illness´s onset).
• (IV) Between one and five years diagnosed with the illness. (V) Able to stand for two min without assistance. (VI) Able to walk teen m without assistance.

You may not qualify if:

• (I) Do not meet the eligibility criteria. (II) Suffer a neurological disease other than Parkinson´s disease.

Sponsors & Collaborators

• University of Oviedo: lead
• University of Leon: collaborator

Study Sites (1)

University of Oviedo

Oviedo, Spain, 33007, Spain

Location

MeSH Terms

Conditions

Neurodegenerative Diseases; Movement Disorders

Condition Hierarchy (Ancestors)

Nervous System Diseases; Central Nervous System Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PhD

Study Record Dates

• First Submitted: December 3, 2024
• First Posted: December 9, 2024
• Study Start: December 1, 2024
• Primary Completion: February 3, 2025
• Study Completion: February 28, 2025
• Last Updated: May 18, 2025

Record last verified: 2025-05

Locations

ES (1)